A systematic review was undertaken to examine the evidence for B-type natriuretic peptides
(BNP and NT-proBNP) as independent predictors of mortality, morbidity, or combined …

Patients with heart failure (HF) are hospitalized over a million times annually in the United
States. Hospitalization marks a fundamental change in the natural history of HF, leading to …

Background We assessed the prognostic significance of absolute and percentage change in
N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients hospitalised for …

Background Readmission after heart failure (HF) hospitalization is an increasing focus for
physicians and policy makers, but statistical models are needed to assess patient risk and to …

For patients presenting with acute dyspnea, an incorrect diagnosis could increase the
mortality risk. When used in the evaluation of patients with acute symptoms, brain natriuretic …

Background Models to stratify risk for patients hospitalised for acute decompensated heart
failure (ADHF) do not include the change in N-terminal pro-B-type natriuretic peptide (NT …

The search for molecules that may contribute to better identify patients at risk for
cardiovascular diseases (CVD) represents today an active field in clinical research. Few …

The natriuretic system consists of the atrial natriuretic peptide (ANP) and four other similar
peptides including the wrongly named brain natriuretic peptide (BNP). Chemically they are …

Background: Acute decompensated heart failure (ADHF) requiring hospitalization is
associated with high postdischarge mortality and readmission rates. Purpose: To examine …

Chronic heart failure (HF) is a leading clinical and public problem posing a higher risk of
morbidity and mortality in different populations. HF appears to be in both phenotypic forms …